JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB180522

Anti-EDEM2 antibody [EPR14043-24]

Be the first to review this product! Submit a review

|

(1 Publication)

Rabbit Recombinant Monoclonal EDEM2 antibody. Suitable for WB and reacts with Human samples. Cited in 1 publication.

View Alternative Names

C20orf31, C20orf49, UNQ573/PRO1135, EDEM2, ER degradation-enhancing alpha-mannosidase-like protein 2

2 Images
Western blot - Anti-EDEM2 antibody [EPR14043-24] (AB180522)
  • WB

Supplier Data

Western blot - Anti-EDEM2 antibody [EPR14043-24] (AB180522)

All lanes:

Western blot - Anti-EDEM2 antibody [EPR14043-24] (ab180522) at 1/2000 dilution

All lanes:

IM9 cell lysate at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution

Predicted band size: 65 kDa

false

Western blot - Anti-EDEM2 antibody [EPR14043-24] (AB180522)
  • WB

Supplier Data

Western blot - Anti-EDEM2 antibody [EPR14043-24] (AB180522)

All lanes:

Western blot - Anti-EDEM2 antibody [EPR14043-24] (ab180522) at 1/10000 dilution

All lanes:

HepG2 cell lysate at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution

Predicted band size: 65 kDa

false

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR14043-24

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>" } } }
style
left-column

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

style
left-column

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle
style
left-column

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The protein EDEM2 is an important part of endoplasmic reticulum-associated degradation (ERAD). It also goes by the name ER degradation-enhancing alpha-mannosidase-like protein 2. This protein is about 66 kDa in mass. EDEM2 is mostly expressed in cells within the endoplasmic reticulum where it carries out its main function. The protein helps in recognizing misfolded glycoproteins and it plays a role in the removal of terminal mannose residues which is necessary for processing and degradation.
Biological function summary

EDEM2 helps ensure protein quality control within cells. It works as part of the ERAD system by targeting misfolded glycoproteins for degradation preventing accumulation of defective proteins that could be harmful to cells. EDEM2 does not act alone but instead functions together with other molecular chaperones and lectin-like proteins to identify and process substrates. This cooperation is essential for maintaining cellular homeostasis and avoiding stress responses.

Pathways

EDEM2 links closely with both protein foldings and quality control mechanisms. It directly interacts with ERAD pathways promoting the disassembly of structurally improper glycoproteins. The action of EDEM2 in these pathways connects with other proteins like SEL1L and HRD1 forming a network that handles aberrant proteins.

EDEM2's role in ERAD pathways relates to conditions like cystic fibrosis and certain neurodegenerative diseases. Misfolded proteins are a known feature in these diseases and EDEM2’s function is essential for managing such protein folding errors. Problems in the activity of EDEM2 or related proteins like OS9 can potentially exacerbate these conditions highlighting the importance of EDEM2 in disease management and potential therapeutic approaches.
style
left-column
style
left-column

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

Target data

Involved in the endoplasmic reticulum-associated degradation (ERAD) pathway that targets misfolded glycoproteins for degradation in an N-glycan-dependent manner (PubMed : 15537790, PubMed : 25092655). May initiate ERAD by promoting the first mannose trimming step of ERAD substrates, from Man9GlcNAc2 to Man8GlcNAc2 (PubMed : 25092655). Seems to recognize and bind to exposed hydrophobic regions in target proteins (By similarity).
See full target information EDEM2
style
left-column

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Journal of translational medicine 23:711 PubMed40597359

2025

Immune profiling identifies CD161CD127CD8 T cells as a predictive biomarker for Anti-PD-L1 therapy response in the SCLC-I subtype.

Applications

Unspecified application

Species

Unspecified reactive species

Jingjing Qu,Wenjia Sun,Yuekang Li,Ziwan Cai,Binggen Wu,Qian Shen,Lijun Chen,Bo Wang,Lixiong Ying,Chenchai Xie,Jing Zheng,Jianya Zhou,Jianying Zhou
View all publications
style
left-column
style
left-column
style
right-column

Alternative Products

Primary Antibodies

AB204173

Anti-EDEM2 antibody

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-EDEM2 antibody (AB204173)

  • 0
  • 0

Complementary Products

Primary Antibodies

AB200645

Anti-EDEM1 antibody

Western blot - Anti-EDEM1 antibody (AB200645)

  • 4
  • 1
Primary Antibodies

AB169766

Anti-CPOX antibody [EPR11927(B)]

RabMAb|Recombinant

Flow Cytometry (Intracellular) - Anti-CPOX antibody [EPR11927(B)] (AB169766)

  • 0
  • 0
Primary Antibodies

AB255865

Anti-Ataxin 3 antibody [EPR22418-147] - BSA and Azide free

RabMAb|Recombinant

Indirect ELISA - Anti-Ataxin 3 antibody [EPR22418-147] - BSA and Azide free (AB255865)

  • 0
  • 0
Primary Antibodies

AB108421

Anti-DcR2 antibody [EPR3588(2)]

BOND RX™ Validated|RabMAb|Recombinant

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-DcR2 antibody [EPR3588(2)] (AB108421)

  • 0
  • 0

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com